HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zhang, J.-Y. Articles by Wang, F.-S. Search for Related Content PubMed PubMed Citation Articles by Zhang, J.-Y. Articles by Wang, F.-S. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Hepatitis B

Cutting Edge: Programmed Death-1 Up-Regulation Is Involved in the Attrition of Cytomegalovirus-Specific CD8⁺ T Cells in Acute Self-Limited Hepatitis B Virus Infection¹

Research Center for Biological Therapy, Beijing 302 Hospital, Beijing, China

Attrition of heterologous virus-specific CD8⁺ T cells has been demonstrated in murine viral infection; however, little is known regarding this phenomenon in human viral infections. In this study, we observed that CMV-specific CD8⁺ T cells displayed numerical decline and functional impairment in the early phase of acute infection, whereas programmed death-1 (PD-1) expression was significantly up-regulated by these CMV-specific CD8⁺ T cells. This early PD-1 up-regulation was found to be closely associated with the increased apoptotic sensitivity of CMV-specific CD8⁺ T cells. The in vitro addition of anti-PD-1 further enhanced the spontaneous apoptosis of CMV-specific CD8⁺ T cells; however, blockade of the PD-1-mediated pathway with anti-PD-L1 significantly restored the CMV-specific CD8⁺ T cell proliferation and IFN- production. Thus, PD-1 plays a crucial role in the attrition of CMV-specific CD8⁺ T cells in acute hepatitis B virus infection, which in turn, influences the preexisting homeostatic virus-specific CD8⁺ T cell pool.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ This study was supported by National Key Basic Research Program of China Grants 2007CB512805 and 2006CB504305 and National Science Fund for Distinguished Young Scholars Grant 30525042.

² J.-Y.Z. and Z.Z. contributed equally to this work.

³ Address correspondence and reprint requests to Dr. Fu-Sheng Wang, Research Center for Biological Therapy, Beijing 302 Hospital, Beijing 100039, China. E-mail address: fswang{at}public.bta.net.cn

⁴ Abbreviations used in this paper: PD-1, programmed death-1; AHB, acute hepatitis B; HBV, hepatitis B virus; HC, healthy control; HBsAg, hepatitis B surface antigen; PD-L1, PD-1 ligand.